Inspire Medical Systems, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NYSE
Inspire Medical Systems achieves its first profitable year in 2024, driven by increased adoption of its Inspire therapy for obstructive sleep apnea.
NYSE
10-K: Inspire Medical Systems Reports 2023 Results, Showing Strong Growth but Potential Challenges Ahead
Inspire Medical Systems, a medical technology company focused on minimally invasive solutions for obstructive sleep apnea, reported its full-year 2023 results, highlighting significant revenue growth and expanding market penetration, but also noting potential headwinds.